Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +49.81%
#3 Glidr Glidr +36.41%
#4 Walrus Walrus +33.05%
#5 Cysic Cysic +22.50%
#6 The Black Bull The Black Bull +19.10%
#7 Tutorial Tutorial +16.25%
#8 Humanity Humanity +14.61%
#9 Nockchain Nockchain +14.30%
#10 Plume Plume +12.86%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Health Sciences Group, Inc. Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESG
Rank in Stocks #37259
Operating through its various subsidiaries, Health Sciences Group Inc. (HESG)... Operating through its various subsidiaries, Health Sciences Group Inc. (HESG) specializes in supplying a range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors across the United States. Key among its offerings is Shugr, an innovative, calorie-free sugar alternative meticulously formulated to replicate the taste and baking properties of traditional cane sugar. Another notable product is the Sequesterol Advance Cardio Formula, a proprietary blend featuring clinically validated ingredients designed to support robust cardiovascular well-being and maintain optimal blood circulation. The company's portfolio further includes Aplevia, an antioxidant extracted from apple peels, and Edible Sponges, an open-cell hydrocolloid product. Distribution channels for these products are diverse, encompassing major retail chains — such as mass merchandisers, pharmacies, grocery stores, and discount outlets — alongside sales to healthcare professionals, practitioners, and various other media platforms. Tracing its origins to 1996 as Centurion Properties Development Corporation, the company underwent a name change to iGoHealthy.com in 2000, before adopting its current designation, Health Sciences Group, Inc., in 2001. Its corporate headquarters are situated in Newport Beach, California.
Share Price
$0.0001
Last synced: 2026-08-13
Market Cap
$1.87M
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
US
Trade Health Sciences Group, Inc. (HESG)

Category

Healthcare
P/E ratio for Health Sciences Group, Inc. (HESG)
P/E ratio as of 2026 TTM: 0
According to Health Sciences Group, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Health Sciences Group, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 18.38 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.